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Abstract
The PI3K-Akt-mTOR pathway plays crucial roles in regulating both innate and adaptive immunity. However, the role of TSC1,
a critical negative regulator of mTOR, in peripheral T cell homeostasis remains elusive. With T cell-specific Tsc1 conditional
knockout (Tsc1 KO) mice, we found that peripheral naı ¨ve CD8
+ T cells but not CD4
+ T cells were severely reduced. Tsc1 KO
naı ¨ve CD8
+ T cells showed profound survival defect in an adoptive transfer model and in culture with either stimulation of
IL-7 or IL-15, despite comparable CD122 and CD127 expression between control and KO CD8
+ T cells. IL-7 stimulated
phosphorylation of Akt(S473) was diminished in Tsc1 KO naı ¨ve CD8
+T cells due to hyperactive mTOR-mediated feedback
suppression on PI3K-AKT signaling. Furthermore, impaired Foxo1/Foxo3a phosphorylation and increased pro-apoptotic Bim
expression in Tsc1 KO naı ¨ve CD8
+T cells were observed upon stimulation of IL-7. Collectively, our study suggests that TSC1
plays an essential role in regulating peripheral naı ¨ve CD8
+ T cell homeostasis, possible via an mTOR-Akt-FoxO-Bim signaling
pathway.
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Introduction
PI3K-Akt-mTOR signaling pathway plays crucial roles in
regulating both innate and adaptive immunity [1–3]. In
mammalian cells, mTOR can form two complexes which are
called mTOR complex1(mTORC1) and mTOR complex2(-
mTORC2), respectively, via binding with different partner
proteins. mTORC1 activity is negatively regulated by a hetero-
dimeric complex composed of TSC1 (hamartin) and TSC2
(tuberin). The TSC1/2–mTOR pathway serves as a central
regulator of cellular metabolism, survival, growth and differenti-
ation through integrating various environmental cues [4–7].
TSC1/2-mTOR signaling pathway regulates the innate inflam-
matory response of macrophages and plasmacytoid dendritic cells
in mice [1,8–10]. Increasing evidence suggests that TSC1/2-
mTOR pathway regulates T cell survival, anergy, trafficking, as
well as the generation of different T cell subset differentiation [11–
20]. However, the detailed role of TSC1/2 complex in naı ¨ve T
cell survival and homeostasis remains to be studied.
In the present study, we generated the T cell-specific Tsc1
knockout mice by crossing Tsc1
loxp/loxp mice with transgenic mice
that carried Lck proximal promoter-mediated Cre recombinase.
We found that mTORC1 activity was significantly increased in
Tsc1 null T cells, CD8
+ but not CD4
+T cells decreased
dramatically in secondary lymphoid organs including spleen and
lymph nodes (LNs) but not in the central lymph organ thymus.
Upon transferring into syngeneic Rag1
2/2 or irradiated immu-
nocompetent recipients, Tsc1 KO naı ¨ve CD8
+ T cells displayed
apparent survival and homeostatic defects. Furthermore, Tsc1 KO
naı ¨ve CD8
+ T cells showed profound survival defects in cell
culture with either IL-7 or IL-15, despite their comparable surface
CD122 and CD127 expression and slightly decreased STAT5
phosphorylation in comparison with WT cells. However, phos-
phorylation of Akt(S473) in response to IL-7 stimulation was
compromised in Tsc1 KO naı ¨ve CD8
+T cells. Collectively, these
data suggest that TSC1 is a critical regulator of naı ¨ve CD8
+ T cell
survival and homeostasis in vivo.
Results
TSC1/2 is preferentially expressed in CD8
+T cells
As a first step in characterizing the physiological function of
TSC1 in mouse T cells, we examined the expression patterns of
Tsc1 in thymus and peripheral lymphoid organs. By Western blot,
we found that TSC1 was expressed in thymus, spleen as well as
peripheral lymph nodes (pLNs), brain served as the positive
control as it has been described to highly express Tsc1/2 (Fig. 1A).
We also employed real-time PCR assay to check the expression
patterns of Tsc1 and Tsc2 in peripheral T cell subsets. Compared
with B cells and CD4
+ T cells, splenic CD8
+ T cells showed higher
expression of Tsc1 and Tsc2 (Fig. 1B). These observations suggest
a potential role for TSC1/2 in T cells, especially in CD8
+ T cells.
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+ T cells, not CD4
+T cells, were significantly
decreased in the periphery of TSC1 KO mice
To study how TSC1/2 regulates the T cell development and
function, we generated mice with specific deletion of Tsc1 in T
cells by crossing Tsc1
loxp/loxp mice with transgenic mice that
carried Lck proximal promoter-mediated Cre recombinase. After
several rounds of crossing, we obtained mice with Tsc1
homozygous deletion in T cells (Lck-cre
+Tsc1
loxp/loxp; Tsc1
KO), Tsc1 heterozygous deletion in T cells (Lck-cre
+ Tsc1
loxp/+)
and wild type Tsc1 in T cells (Tsc1
loxp/loxp). Deletion of Tsc1
exons 17 and 18 by Lck-Cre-mediated recombination specifically
in peripheral CD4
+ and CD8
+T cells but not in B cells was
detected (Fig. 1C–E). By Western blot, we found TSC1 expression
was almost absent in thymocytes of Lck-cre
+Tsc1
loxp/loxp(Tsc1
KO) mice, consequently TSC2 expression was also diminished as
TSC1 was previously described to stabilize TSC2 [21,22],
indicating the efficient removal of TSC1/2 specifically in T cells
(Fig. 1F). Consistently, we observed the increased level of S6
phosphorylation in Tsc1 KO thymocytes, which demonstrated
that mTORC1 activity was significantly increased in the absence
of TSC1 in T cells (Fig. 1F). S6 phosphorylation was also increased
in peripheral CD4
+ and CD8
+ T cells of Tsc1 KO mice and was
suppressed by rapamycin (data not shown).
We next determined whether Tsc1/2 deficiency affected the
composition of T cell compartments in peripheral and central
lymphoid organs. As shown in Fig. 2, the total thymic cell number,
and the percentage and cell number of CD4 or CD8 single positive
cells in the thymus of Tsc1 KO mice were identical as WT
littermates (Fig. 2A). No significant alteration for the cellularity in
peripheral organs including spleen, pLNs and mesenteric lym-
phoid nodes (mLNs) in Tsc1 KO mice compared with age- and
sex-matched WT littermate. However, the percentage of CD8
+T
cells decreased dramatically in all peripheral lymphoid organs of
Tsc1 KO mice (Fig. 2B and C, P,0.001), whereas the frequency
of CD4
+T cells was comparable between Tsc1 KO mice and
control littermates. The decreased level of CD8
+T cells in
peripheral lymphoid organs was not due to the enhanced
migration of CD8
+T cells into liver and lung, as we found the
percentages and total cell number of CD8
+T cells in the livers of
WT or Tsc1 KO mice were comparable (Figure S1). Consistently,
the frequency of B220
+ cells was increased in pLNs and mLNs of
Tsc1 KO mice. The absolute number of CD8
+ but not CD4
+T
cells was significantly decreased in these organs of Tsc1 KO mice
(data not shown). Thus, the ratio of CD4
+ to CD8
+T cells
increased significantly in pLNs of Tsc1 KO mice as well
(5.2560.47 compared with 2.0360.25). The increased ratios of
CD4
+ to CD8
+T cells were also observed in spleens as well as
mLNs of Tsc1 KO mice.
To further determine the phenotype or activation status of T
cells in Tsc1 KO mice, the expression of naı ¨ve, effector/memory
Figure 1. Generation of the T cell-specific Tsc1 KO mice. (A) Western blot analysis showed TSC1 was expressed in thymus, spleen as well as
pLNs of WT B6 mice, brain serves as the positive control. (B) Tsc1 and Tsc2 expression level in splenic CD8
+T cells was higher than that in B cells and
CD4
+T cells as detected by Real-time PCR analysis. *p,0.05; **p,0.01; ***p,0.001 compared with the indicated groups. Date were shown as
Mean6SD (N=6). (C) Schematic representation of deletion of Tsc1 exons 17 and 18 by Lck-Cre-mediated recombination in T cells. (D) Genotyping of
wild type (Tsc1
+/+, WT), heterozygous(Lck-cre
+Tsc1
loxp/+, HE) and knockout (Lck-cre
+Tsc1
loxp/loxp, KO) mice with tail genomic DNA. (E) Detection of
Tsc1 deletion in purified CD8
+T cells, CD4
+T cells and non-T cells from spleen of Tsc1 KO mice. Tsc1 was specifically deleted in T cells. (F) Western blot
analysis showed efficient deletion of TSC1 and TSC2 protein expression in thymocytes. Phosphorylated S6 level was significantly increased in Tsc1 KO
mice.
doi:10.1371/journal.pone.0030592.g001
Role of TSC1/2 in Naı ¨ve CD8
+T Cell Homeostasis
PLoS ONE | www.plosone.org 2 February 2012 | Volume 7 | Issue 2 | e30592surface markers including CD62L, CD45RB and CD44 on either
CD4
+ or CD8
+T cells was evaluated using FCM. Though the
frequency of naı ¨ve CD62L
hi, CD45RB
hi and CD44
low CD4
+T
cells in spleen, pLNs and mLNs of Tsc1 KO mice was kept normal
as WT mice (Fig. 2D), remarkably decreased percentages of naı ¨ve
CD62L
hi, CD45RB
hi and CD44
low CD8
+T cells in spleen, pLNs
and mLNs of Tsc1 KO mice were observed (Fig. 2E, P,0.001).
The reduction of peripheral naı ¨ve CD8
+T cells in Tsc1 KO mice
was not caused by Cre-induced toxicity, as Lck-cre+, Tsc1
loxp/
+mice showed normal levels of peripheral naı ¨ve CD8
+T cells. The
different expression intensity of TSC1/2 in CD4
+ and CD8
+T
cells and the distinct alteration of CD4
+ and CD8
+T cells in the
periphery of Tsc1 KO mice collectively indicates that TSC1/2
may play differential roles in regulating T cell subsets in mice.
TSC1 is required for naive CD8
+ T cell survival and
homeostasis in vivo
Based on our data mentioned above, we speculated that
peripheral survival deficiency of naı ¨ve CD8
+T cells might exist in
Tsc1 KO mice. To test this hypothesis, we employed mouse
models with an adoptive transfer of sorted syngeneic naı ¨ve CD8
+T
cells as well as the in vitro IL-7 and IL-15-dependent naı ¨ve CD8
+T
cell survival assays to address the effect of TSC1/2 on the survival
capacity of peripheral naı ¨ve CD8
+T cells.
Adoptive transfer mouse models were commonly employed in
studies of peripheral T cell survival and homeostasis [23,24]. By one
week after adoptive transfer of sorted either CD45.2
+ WT or
CD45.2
+Tsc1 KO naı ¨ve CD8
+Tc e l l si n t oR a g
2/2 syngeneic
recipients (Fig. 3A), significantly lower percentages and cell number
of Tsc1 KO naı ¨ve CD8
+ T cells in spleens and pLNs of recipients
wereobservedcomparedwithWTnaı ¨ve CD8
+Tc e ll s( F i g .3 Ba n dC ,
P,0.001). When both CD45.2
+Tsc1 KO and CD45.1
+WT naı ¨ve
CD8
+T cells at a ratio of 1:1 were simultaneously transferred into
Rag1
2/2 mice (Fig. 3D), the ratio of WT to Tsc1KO naı ¨ve CD8
+T
cells increased to 2.660.4:1 and 5.060.9:1 in spleens and pLNs of
recipients, respectively. The percentages and cell number of Tsc1
KO naı ¨ve CD8
+T cells were significantly lower than those of WT
naı ¨ve CD8
+T cells in spleens and pLNs as well (Fig. 3E and F,
P,0.001). As Rag1
2/2 mice were T/B cell deficient and might drive
extensive homeostatic proliferation of naive T cells due to
Figure 2. Naı ¨ve CD8
+ but not CD4
+ T cells were significantly decreased in the periphery of Tsc1 KO mice. The peripheral T cell subsets of
WT and Tsc1 KO mice were detected using FCM 4–5 wks after birth. A. Total thymic cell number and thymocyte subset profile of Tsc1 KO mice were
identical as WT littermates. B. Total cell number of spleen, pLNs and mLNs of WT and Tsc1 KO mice. C. The percentage of CD8
+T but not CD4
+T cells
decreased dramatically in all peripheral lymphoid organs of Tsc1 KO mice. D. The FACS profile analysis of CD62L, CD45RB and CD44 on pLN CD4
+ T
cells was evaluated. The frequency of naı ¨ve CD62L
hi, CD45RB
hi and CD44
low CD4
+T cells in spleen, pLN and mLN of Tsc1 KO mice was summarized. E.
The FACS profile analysis of CD62L, CD45RB and CD44 on the gated pLN CD8
+ T cells was evaluated. The frequency of naı ¨ve CD62L
hi, CD45RB
hi and
CD44
low CD8
+T cells in spleen, pLN and mLN of Tsc1 KO mice was summarized. *p,0.05; **p,0.01; ***p,0.001. Data were shown as Mean6SD
(N=6).
doi:10.1371/journal.pone.0030592.g002
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+Tsc1
KO or CD45.2
+WT naı ¨ve CD8
+T cells into 4Gy-irriadiated
immunocompetent CD45.1
+syngeneic C57BL/6 recipients
(Fig. 3G). Consistent with the results in T cell-deficient recipients,
significantly decreased percentage and cell number of CD45.2
+Tsc1
KO CD8
+T cells were detected in irradiated immunocompetent B6
recipient mice compared with CD45.2
+WT naı ¨ve CD8
+Tc e l l s
(Fig. 3H and I, P,0.001). This was not due to proliferative deficiency
as these CD45.2
+Tsc1 KO CD8+ T cells incorporated comparable
l e v e lo fB r d Ua st h a to fC D 4 5 . 2
+WT naı ¨ve CD8
+ T cells (data not
shown). Moreover, it might not be caused by peripheral migration or
trafficking defects of Tsc1 KO naı ¨ve CD8
+Tc e l l s ,b e c a u s ew ef o u n d
significantly decreased percentages of Tsc1 KO naı ¨ve CD8
+Tc e l l si n
all peripheral lymphoid tissues such as PBL, spleen, pLNs as well as
mLNs (Fig. 3H and I). Taken together, these data suggest that TSC1
is a critical regulator of naı ¨ve CD8
+ T cell survival and homeostasis in
vivo.
The poor response to IL-7 and IL-15 of Tsc1 KO naive
CD8
+ T cells in vitro
The peripheral T cell pool is constant throughout life and active
maintenance of accurate peripheral naı ¨ve T cell pool depends on
multiple homeostatic mechanisms [25–29]. Survival of naı ¨ve
CD8
+T cells is dependent on the presence of MHC I binding to
peptide antigens [30]. In addition to TCR signals, cytokines such
as IL-7 and IL-15 are critically required for the homeostatic
survival of naı ¨ve T cells [23,31–35], via the substantial induction
of anti-apoptotic Bcl-2 expression or destabilization of p27
Kip1
[36–38]. To determine whether Tsc1 KO naı ¨ve CD8
+T cells were
refractory to IL-7 and IL-15 mediated survival or not, we
Figure 3. TSC1 is required for naive CD8
+ T cell homeostasis in adoptive transfer mouse models. Sorted naı ¨ve CD8
+T cells were
adoptively transferred into syngeneic Rag1
2/2 or irradiated recipients. The levels of transferred naı ¨ve CD8
+T cells in spleen and pLNs of recipients
were determined 7 days after transfer. (A) Schematic representation of adoptive transfer of either WT or Tsc1 KO CD45.2
+ naı ¨ve CD8
+ T cells into
Rag
2/2 host. (B) One representative staining of CD8
+T cells in pLN of Rag1
2/2 mice after transfer of sorted naı ¨ve CD8
+T cells. (C) Tsc1 KO CD45.2
+
naı ¨ve CD8
+ T cells showed homeostatic defect in spleen and pLNs. Statistic analysis of percentage and numbers of transferred CD8
+T cells in spleen as
well as pLN. (D) Schematic representation of adoptive transfer of mixed(1:1) population of WT CD45.1
+ and Tsc1 KO CD45.2
+ naı ¨ve CD8
+T cells into
Rag
2/2 host. (E) One representative staining of CD45.1 and CD45.2 on gated CD8
+T cells in pLNs of Rag1
2/2 mice 7 days after transfer of sorted naı ¨ve
CD8
+T cells. (F) The ratio between WT CD45.1
+CD8
+ and Tsc1 KO CD45.2
+CD8
+ T cells as well as the frequency of CD45.1
+ or CD45.2
+CD8
+ T cells in
spleen and pLNs were summarized. (G) Schematic representation of adoptive transfer of either WT or Tsc1 KO CD45.2
+ naı ¨ve CD8
+ T cells into
sublethally irradiated(4 Gy) CD45.1
+ host. (H) One representative staining of CD45.1 and CD8 for pLN cells of recipients 7 days after transfer of sorted
naı ¨ve CD8
+T cells. (I) Lower percentage and cell number of Tsc1 KO CD45.2
+ naı ¨ve CD8
+ T cells in spleen and pLNs. *p,0.05, **p,0.01, and
***p,0.001 compared with WT group. Data were shown as Mean6SD (3–5 mice each group). One representative of two or three independent
experiments with identical results was shown.
doi:10.1371/journal.pone.0030592.g003
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+T cell survival ability in the
presence or absence of IL-7 or IL-15 in vitro. As shown in Fig. 4,
significantly increased survival frequency of WT naı ¨ve CD8
+T
cells by IL-15 or IL-7 was observed after culture for 24 hours.
However, Tsc1 KO naı ¨ve CD8
+ T cells displayed impaired
survival upon stimulation with IL-7 or IL-15 for 24 hours (Fig. 4A,
P,0.001). Consistently, naı ¨ve CD8
+T cells isolated from Tsc1 KO
mice exhibited significantly more cell death than WT cells by
24 hours in the presence of IL-7 and IL-15 in vitro as determined
by cell atrophy (Fig. 4B) and PI staining (Fig. 4C and D).
It was reported that loss of TSC1 in cells resulted in mTOR
hyper-activation [22], we thus added mTOR inhibitor, rapamycin
(Rapa), into the naı ¨ve CD8
+T cell culture system with IL-7. The
survival defects of Tsc1KO naı ¨ve T cells in response to IL-7 was
not rescued by Rapa treatment in vitro (Fig. 4A, P.0.05). Likewise,
we treated CD45.2
+ WT or Tsc1 KO naı ¨ve CD8
+T cell-
transferred CD45.1
+ B6 mice with Rapa (i.p.) for 1 week, Rapa
increased the percentage of both WT or Tsc1 KO naı ¨ve
CD45.2
+CD8
+T cells in spleens and pLNs, possibly due to higher
sensitivity to Rapa of other immune cells. However, significantly
decreased cell number of WT and Tsc1 KO naı ¨ve
CD45.2
+CD8
+T cells was observed in the presence of Rapa.
Importantly, Rapa treatment failed to rescue the survival defect of
Tsc1 KO naı ¨ve CD8
+T cells in vivo (Fig. 4E–G, P.0.05). These
data collectively indicate that TSC1/2 may regulate naı ¨ve CD8
+T
cell survival in Rapa-insensitive manner.
Figure 4. TSC1 regulates naı ¨ve CD8
+ T cell survival to IL-7 or IL-15 in a rapamycin-insensitive manner. Sorted WT and Tsc1 KO mouse
naı ¨ve CD8
+CD44
low T cells were cultured in medium alone or supplemented with IL-15 or IL-7(in the presence or absence of Rapa) for 24 hrs or the
below indicated time points. (A) Significantly decreased live cell number of Tsc1 KO naı ¨ve CD8
+T cells than WT naı ¨ve CD8
+T cells in the presence of IL-
15 or IL-7 for 24 hours. Live cells were determined by trypan blue exclusion assay. (B) Tsc1 KO naı ¨ve CD8
+ T cells showed severe atrophy in the
presence of IL-7 for 24 hrs. (C) One representative of PI staining in gated CD8
+T cells after culture with or without IL-7 and IL-15. (D) Percentage of cell
death was measured by PI staining and statistically analyzed. The above data were one representative of three separate experiments, with three wells
in each group. (E) Representative staining of CD45.2 and CD8 for pLN cells of CD45.1
+ host in the presence or absence of Rapa 7 days after transfer.
Either sorted WT or Tsc1 KO CD45.2
+ naı ¨ve CD8
+ T cells were adoptively transferred into sublethally irradiated(4 Gy) CD45.1
+ host and the donor cells
were determined by CD8 and CD45.2 staining. (F) Significantly decreased percentage and cell number of Tsc1 KO CD45.2
+ naı ¨ve CD8
+ T cells in
spleen of sublethally irradiated (4 Gy) CD45.1
+ host in the presence or absence of Rapa. (G) Significantly decreased percentage and cell number of
Tsc1 KO CD45.2
+ naı ¨ve CD8
+ T cells in pLNs of sublethally irradiated (4 Gy) CD45.1
+ host in the presence or absence of Rapa. Data were shown as
Mean6SD (3 mice each group). *p,0.05; **p,0.01; ***p,0.001 compared with the indicated groups.
doi:10.1371/journal.pone.0030592.g004
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Tsc1 KO naı ¨ve CD8
+ T cells in response to IL-7 stimulation
It was previously reported that CD127(IL-7Ra) expression is
highly required for CD8
+T cell survival and homeostatic
proliferation. To investigate the potential reason for the survival
defects of Tsc1 KO naı ¨ve CD8
+T cells in response to IL-7 or IL-
15, we first examined the expression levels of CD127, CD122(IL-
15Rb) or CD132(cc chain) in naı ¨ve CD8
+T cells of WT or Tsc1
KO mice. However, cell surface CD127, CD122 or CD132
expression on Tsc1 KO naı ¨ve CD8
+T cells was similar as WT
CD8
+T cells (Fig. 5A). Tsc1 KO naı ¨ve CD8
+ T cells did not
express increased levels of the death receptor Fas compared with
WT naı ¨ve CD8
+ T cells (Fig. 5B). IL-7 causes STAT5
phosphorylation via activation of Jak1 or Jak3. In this respect,
IL-7 promotes cell survival by preventing the mitochondrial
pathway of apoptosis, among which Bcl-2 is the predominant one
[37], whereas other anti-apoptotic molecules such as Bcl-xl are
barely expressed in naı ¨ve T cells. Upon IL-7 stimulation, we found
slightly decreased STAT5 phosphorylation in Tsc1 KO naı ¨ve
CD8
+ T cells. Phosphorylation of Akt(S473) in Tsc1 KO naı ¨ve
CD8
+ T cells was not evident after IL-7 stimulation while IL-7
induced significant amount of Akt(S473) phosphorylation in WT
naı ¨ve CD8
+ T cells(Fig. 5C). It is reported that phosphorylation of
Akt is important for FoxO1(Thr24) and FoxO3a(Thr32) phos-
phorylation which critically regulates FoxO1/FoxO3a transcrip-
tional activity [39]. Once phosphorylated, FoxO1/FoxO3a is
excluded from the nucleus and becomes transcriptionally inactive.
In the present study, IL-7 treatment induced significantly higher
level of FoxO1(Thr24) and FoxO3a(Thr32) phosphorylation in
WT naı ¨ve CD8
+T cells but not in Tsc1 KO naı ¨ve CD8
+T cells.
It is well known that naı ¨ve T cell survival critically depends on
the balanced expression of the pro-survival Bcl-2 and pro-
apoptotic protein Bim [37]. Phosphorylated forms of FoxO3a
directly inhibits the pro-apoptotic Bim expression to maintain
central memory CD4
+T cells(CD4
+TCM) longevity and persistence
in mice [40]. In IL-7 treated Tsc1 KO naı ¨ve CD8
+T cells, Bim L
expression was dramatically increased which was consistent with
absence of Akt-mediated FoxO1(Thr24) and FoxO3a(Thr32)
phosphorylation, while no Bim L expression was detected in IL-
7-treated WT naı ¨ve CD8
+T cells, even though both cells expressed
similar levels of Bim EL(Fig. 5C). In addition, the Bcl-2 and Bax
expression in Tsc1 KO naı ¨ve CD8
+ T cells were identical with
WT naı ¨ve CD8
+T cells even in the presence of IL-7, excluding the
possibility that the involvement of Bcl-2/Bax-related pathways in
TSC1-mediated survival of naı ¨ve CD8
+T cells.
Discussion
In the present study, using adoptive transfer mouse models, we
clearly demonstrates that TSC1/2 signaling complex, an impor-
tant negative regulator of mTOR, is essential for peripheral naı ¨ve
CD8
+T cell survival and homeostasis, which is consistent with
recent studies(Fig. 6) [19,20]. The defects of naı ¨ve CD8
+T cell
survival in the periphery of Tsc1 KO mice are largely intrinsic to
mature peripheral naı ¨ve CD8
+T cells, as evidenced by the poor
survival of Tsc1 KO naive CD8
+T cells when both WT and Tsc1
KO naı ¨ve CD8
+T cells were co-transferred into synegeneic
recipient mice. The normal distribution of thymocyte subsets
and peripheral CD4
+T cells in Tsc1 KO mice indicate that the
distinct role of TSC1/2 signaling complex in peripheral naı ¨ve
CD8
+T cells at least in mice. The differential effects of TSC1/2
signaling complex on CD4
+ and CD8
+T cells are possibly related
to the higher Tsc1/2 expression in CD8
+T cells than CD4
+T cells.
CD127 expression is required for naı ¨ve CD8
+T cell survival and
homeostatic proliferation. In Tsc1 KO naı ¨ve CD8
+T cells, we
failed to find significantly decreased expression of cell surface
Figure 5. Decreased Akt-FoxO1/FoxO3a phosphorylation of Tsc1 KO naı ¨ve CD8
+T cells in response to IL-7. The expression of CD122,
CD127 and CD95 on naı ¨ve CD8
+T cells was determined by gating CD8
+CD44
low cells. Comparable surface CD122, CD127 (A) and CD95 (B) expression
in Tsc1 KO naı ¨ve CD8
+ T cells. The dash-dot line represents staining with an isotype control antibody. The histograms (gray) represent WT whereas the
open histograms with solid line show Tsc1 KO staining pattern. Cells are gated with CD8
+CD44
low population. Representative data are shown from
one of two separate experiments, with three mice in each group. (C) Western blot analysis of mTORC2-Akt-FoxO1/FoxO3a-Bim axis in naı ¨ve CD8
+ T
cells after stimulation with IL-7. Sorted naı ¨ve CD8
+T cells were cultured with IL-7 in the presence of Rapa or not for 24 hrs. The freshly isolated WT or
Tsc1 KO naı ¨ve CD8
+T cells were used as a control. One representative is shown from two or three separate experiments.
doi:10.1371/journal.pone.0030592.g005
Role of TSC1/2 in Naı ¨ve CD8
+T Cell Homeostasis
PLoS ONE | www.plosone.org 6 February 2012 | Volume 7 | Issue 2 | e30592CD127, CD122 or CD132, suggesting that TSC1/2 signaling
complex does not regulate IL-7 or IL-15 receptor expression on
naı ¨ve CD8
+T cells. In addition, Tsc1 KO naı ¨ve CD8
+ T cells did
not up-regulate Fas expression compared with WT naı ¨ve CD8
+ T
cells. Our data rule out the possibility that the poor survival of
Tsc1 KO naı ¨ve CD8
+T cells is due to the decreased cytokine
receptor expression or increased cell death receptor expression.
IL-7 initiates Jak1 or Jak3 activation which followed by STAT5
phosphorylation and promotes cell survival mainly through anti-
apoptotic Bcl-2 up-regulation. Upon IL-7 stimulation, Bcl-2 up-
regulation was not disrupted in Tsc1 KO naı ¨ve CD8
+ T cells
though STAT5 phosphorylation level was slightly decreased.
Moreover, the pro-apoptotic Bax expression was similar between
IL-7 stimulated Tsc1 KO naı ¨ve CD8
+ T cells and WT cells,
excluding the possibility that the involvement of Bcl-2/Bax
associated pathways in TSC1-mediated survival of naı ¨ve CD8
+T
cells.
In our study, phosphorylation of Akt(S473) in Tsc1 KO naı ¨ve
CD8
+T cells was compromised after IL-7 stimulation while IL-7
induced a significant increase of Akt(S473) phosphorylation in WT
naı ¨ve CD8
+ T cells. Our study suggested that absence of Tsc1
caused a severe deficiency of IL-7 or IL-15-induced Akt activation
in naı ¨ve CD8
+ T cells. Ser473 phosphorylation is important for
FoxO1(Thr24) and FoxO3a(Thr32) phosphorylation which plays
an essential role in control of T cell homeostasis [24,40,41]. In WT
naı ¨ve CD8
+T cells, IL-7 induced significantly higher level of
FoxO1(Thr24) and FoxO3a(Thr32) phosphorylation. However,
IL-7 failed to induce FoxO1(Thr24) and FoxO3a(Thr32) phos-
phorylation in Tsc1 KO naı ¨ve CD8
+T cells, which was consistent
with the deficiency of Akt phosphorylation and activation in these
cells. It was recently demonstrated that phosphorylated forms of
FoxO3a could directly inhibit the pro-apoptotic Bim expression to
maintain central memory CD4
+T cells(CD4
+TCM) longevity and
persistence in mice [40]. In the present study, we found that Bim L
expression was dramatically increased in IL-7 treated Tsc1 KO
naı ¨ve CD8
+T cells, while no Bim L expression was detected in IL-
7-treated WT naı ¨ve CD8
+T cells, even though both cells expressed
similar levels of Bim EL.
Taken together, TSC1 critically regulates peripheral naı ¨ve
CD8
+T cell survival and homeostasis. Loss of TSC1 leads to
mTOR-mediated inhibition of PI3K-AKT in naı ¨ve CD8
+T cells.
The TSC1/2-mTOR-Akt-FoxO-Bim anti-apoptosis pathway is
essential in the maintenance of naı ¨ve CD8
+T cell survival and
homeostasis in mice.
Materials and Methods
Animals
Tsc1
loxp/loxp mice were generated by D.J. Kwiatkowski [42]. T
cell specific Tsc1 conditional knockout mice were obtained by
crossing Tsc1
loxp/loxp mice with transgenic mice that carried Lck
proximal promoter-mediated Cre recombinase which had a
C57BL/6J background (Kindly provided by Dr. Hua Han) [43].
After multiple rounds of crossing, we obtained homozygous mutant
mice lacking Tsc1 in T cells (Lck-cre
+Tsc1
loxp/loxp) and heterozy-
gous mice (Lck-cre
+Tsc1
loxp/+) mainly in C57BL/6 backgrounds.
Both Lck-Cre-, Tsc1
loxp/loxp and Lck-cre
+Tsc1
loxp/+ mice served as
control. Rag1
2/2 mice were obtained from Center of Model
Animal Research at Nanjing University, China. All animals were
maintained in microisolator cages in a specific-pathogen free
facility. All experiments were approved by the Animal Ethics
Committee of the Institute of Zoology (IOZ2008012).
mAbs and chemical reagents
The following mAbs were purchased from BD Biosciences
PharMingen (San Diego, CA): anti-mCD4-FITC, anti-mTCRb-
PE, anti-mCD8a-PE, anti-mCD44-PE, anti-mCD45RB-PE, anti-
mCD62L-PE, anti-mCD95-FITC, anti-mCD122-PE, anti-
Figure 6. Schematic illustration of TSC1 in regulating naı ¨ve CD8
+T cell survival in response to IL-7. (A) IL-7 stimulation triggers PI3K-Akt
activation in naı ¨ve CD8
+ T cells, which followed by FoxO1/FoxO3a phosphorylation. FoxO1/FoxO3a phosphorylation leads to their translocation into
the cytoplasm from the nucleus, in this regard, naı ¨ve CD8
+ T cell survival was maintained as the pro-apoptotic Bim expression was turned off. (B)
Absence of TSC1 causes hyper-activation of mTOR which leads to suppression of PI3K-Akt signaling pathway. IL-7 stimulation of Akt activation is
compromised in Tsc1 KO naı ¨ve T cells and thus Akt-dependent phosphorylation of FoxO1/FoxO3a is decreased. The accumulation of FoxO1/FoxO3a
in the nucleus drives the pro-apoptotic Bim expression which promotes naı ¨ve CD8
+ T cell death.
doi:10.1371/journal.pone.0030592.g006
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obtained from Biolegend (San Diego, CA). Rapamycin (Rapa; LC
laboratory, Rapa) was reconstituted in ethanol at 60 mg/mL and
then diluted in the vehicle containing sodium CMC (C-5013 high
viscosity, Sigma-Aldrich) and polysorbate 80. Rapa was adminis-
tered intraperitoneally at a dose of 4 mg/kg every other day for 14
days. 0.2% CMC and 0.25% polysorbate 80 was administered as
control solution.
Quantitative real-time PCR assay
RNA was extracted with RNAeasy Mini kits (Omega) and was
reversely transcribed into cDNA, real-time PCR was performed
according to the manufacturer’s instructions(Takara). The starting
quantity of Tsc1and Tsc2 was normalized to the starting quantity
of housekeeping gene Hprt for each sample. Primers were used in
the present study as follows: TSC1 Sense: 59-AAGCATCCTGA-
CACCACCAAG-39;
Reverse: 59-GGATCTCCAGTTCCAACACCC-39;
TSC2 Sense: 59-CTTAGGTGGACTGGATGTATGTGG-39;
Reverse: 59-TTGAACTGGCCCTTAATGGTG-39
HPRT Sense: 59-AGTACAGCCCCAAAATGGTTAAG-39;
Reverse: 59-CTTAGGCTTTGTATTTGGCTTTTC-39.
Immunofluorescence staining and flow cytometry (FCM)
Cells of peripheral LNs(pLNs), mesenteric LNs(mLNs), spleno-
cytes and thymocytes were prepared and washed twice with ice-
cold FACS buffer (PBS, pH 7.2, containing 0.1% NaN3 and 0.5%
BSA). 5610
5 cells were resuspended in 100 mL FACS buffer and
blocked by anti-mouse FcR mAb (2.4G2) followed by incubation
with fluorochrome conjugated mAbs at 4uC for 30 minutes. Cells
were washed twice with FACS buffer and at least ten thousand
cells were assayed using a FACS Calibur (Becton Dickinson, CA)
or Beckman Coulter Epics XL, and data were analyzed with
CellQuest software.
Isolation of liver lymphocytes
Four-to-5 week old mice were anesthetized and the liver was
perfused with PBS containing heparin with a needle inserted into
the portal vein. The liver was then removed and thoroughly
dissected and passed through a 200-gauge stainless steel mesh, cells
were suspended in RPMI 1640 medium containing 10% FBS and
centrifuged. The pellet was resuspended in 40% Percoll solution
containing 100 U/ml heparin, and then gently loaded on the layer
of 70% Percoll solution followed by centrifugation at 2,000 rpm
for 20 min at room temperature. The cells were collected from the
Percoll interface and harvested by centrifugation and washed twice
with FACS buffer.
Adoptive transfer experiment
Naı ¨ve CD8
+CD44
low T cells were purified from pLNs of
CD45.1 (WT) or CD45.2(Tsc1 KO) mice by FACS
TM Aria II.
The purity and viability of enriched naı ¨ve CD8
+T cells were
approximately 98.5% or above. Cells were adoptively transferred
into Rag1
2/2 mouse recipients either separately or at 1:1
ratio(3610
5 cells each). CD45.1 mice were sub-lethally irradia-
ted(4 Gy) and transferred with either 6610
5 CD45.2(wild-type) or
CD45.2(Tsc1 KO) naı ¨ve CD8
+CD44
low T cells. Seven days after
cell transfer, mice were sacrificed and peripheral lymphoid organs
were collected, the percentage and absolute number of donor
CD8
+ T cells gated on CD45.1 or CD45.2 were analyzed and
calculated.
Naı ¨ve CD8
+T cell culture
The sorted naı ¨ve CD8
+CD44
low T cells were cultured in
RPMI1640 supplemented with 10% FBS, 25 mM HEPES, 2 mM
L-glutamine, 100 IU/mL of penicillin, 100 mg/mL streptomycin
and 50 mM 2-mercaptoethanol (Sigma, St. Louis, MO, USA).
Where indicated, IL-7 or IL-15 was supplemented into media at a
concentration of 10 ng/mL (Miltenyi Biotech) and 50 ng/
mL(PeproTech), respectively. Trypan blue exclusion assay and
PI staining were used to determine the cell viability of sorted naı ¨ve
CD8
+CD44
low T cells at indicated time points.
Western blot analysis
Cells were collected and wash twice with PBS and then lysed for
30 minutes on ice in RIPA solution containing protease inhibitor
cocktails (Roche) together with phosphatase inhibitors (Sigma) as
described previously. Equivalent protein concentrations were
subjected to 8–12% SDS-PAGE (Bio-Rad, Hercules, CA). Rabbit
anti–TSC1(#4906), rabbit anti–pS6(S235/236, #4858), rabbit
anti–pS6(S240/244, #4838), rabbit anti-pAkt(S473, #4058),
rabbit anti-pSTAT5(#4906), rabbit anti- pFoxO1/FoxO3a
(#9464) and rabbit anti-Bim(#2933) were purchased from Cell
Signaling Technology. Rabbit anti–TSC2(#1613-1) was pur-
chased from Epitomics. Rabbit anti–Bcl-2(sc-7382, Santa Cruz
Biotechnology, CA) or mouse anti-Beta-actin(Sigma-Aldrich).
HRP labeled goat anti-rabbit IgG (Invitrogen, CA) and HRP
labeled goat anti-mouse IgG were used. Contrast and brightness
were adjusted uniformly for each image.
Statistical analysis
All data are presented as the mean+SD. Student’s unpaired t
test for comparison of means was used to compare groups. A P
value less than 0.05 was considered to be statistically significant.
Supporting Information
Figure S1 The normal percentage and cell number of
CD8
+ T cells in the livers of Tsc1 KO mice. Lymphocytes
isolated from livers of WT or Tsc1 KO mice were stained with
anti-CD45 and CD8 mAbs (A). The percentage (B) and total cell
number (C) of CD45
+CD8
+ T cells in livers of WT or Tsc1 KO
mice were summarized. One representative of two independent
experiments with identical results was shown. No significant
difference between WT and Tsc1KO mice was observed
(P.0.05).
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